Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the study record for the completed KEYNOTE-180 pembrolizumab trial in advanced esophageal or esophagogastric junction cancer, with its study details, results measures, and supporting documents.
    Difference
    46%
    Check dated 2026-11-09T13:55:48.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T15:49:36.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T16:45:07.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision advanced from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T20:51:42.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T03:49:15.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Access to the study page now displays a 403 Forbidden error instead of the study record content, blocking the trial details. The change replaces the page content with an error screen while keeping the site chrome visible.
    Difference
    18%
    Check dated 2026-09-21T22:30:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.